Harrow HROW
NASDAQ HROW
$37.74 -0.10 (-0.28%)
As of: Sep 9, 2026 · 12:53 PM EDT

Harrow (HROW) Non Operating Investment Income (2017 - 2024)

Harrow (HROW) posted Non Operating Investment Income of -$1.9 million for Q2 2024, down 54.09% on a QoQ basis from -$1.2 million in Q1 2024, and down 169.33% year-over-year from $2.8 million in Q3 2023.

Analysis

Harrow (HROW) Non Operating Investment Income (2017 - 2024) Analysis & Trends

Harrow has reported Non Operating Investment Income for 8 years, with the latest figure at -$1.9 million in Q2 2024.

  • On a quarterly basis, Non Operating Investment Income fell 169.33% year-over-year to -$1.9 million in Q2 2024; TTM through Dec 2024 was -$3.2 million, a 202.55% decrease from a year earlier, with the FY2024 full-year figure at -$3.2 million, down 202.55% from the prior year.
  • Non Operating Investment Income was -$1.9 million for Q2 2024 at Harrow, down from -$1.2 million in the prior quarter.
  • The five-year high for Non Operating Investment Income was $8.6 million in Q3 2020, with the low at -$10.8 million in Q1 2020.
  • Average Non Operating Investment Income over 5 years is -$1.1 million, with a median of -$1.1 million recorded in 2022.
  • The sharpest annual moves came in 2020 and 2023: Non Operating Investment Income sank 1332.29% in 2020, then soared 1369.06% in 2023.
  • Over 5 years, Non Operating Investment Income stood at $805000.0 in 2020, then plunged by 284.72% to -$1.5 million in 2021, then surged by 195.97% to $1.4 million in 2022, then slumped by 70.85% to $416000.0 in 2023, then plunged by 562.26% to -$1.9 million in 2024.
  • The last three Non Operating Investment Income figures came in at -$1.9 million (Q2 2024), -$1.2 million (Q1 2024), and $416000.0 (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Johnson & Johnson 642.70 Bn 621.95 Bn 17.26 Bn -
2 AbbVie 440.80 Bn 434.23 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.37 Bn 258.68 Bn 11.24 Bn -
5 Pfizer 158.89 Bn 147.19 Bn 10.94 Bn -
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -
7 Revolution Medicines 44.38 Bn 44.38 Bn - -
8 Incyte 25.28 Bn 20.74 Bn 1.57 Bn 9.81 Mn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn -
10 Harrow 1.41 Bn 1.32 Bn 50.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1.92 Mn
Mar 31, 2024 -1.25 Mn
Dec 31, 2023 416,000.00
Sep 30, 2023 1.35 Mn
Jun 30, 2023 -714,000.00
Mar 31, 2023 2.04 Mn
Dec 31, 2022 1.43 Mn
Sep 30, 2022 -1.03 Mn
Jun 30, 2022 -3.45 Mn
Mar 31, 2022 139,000.00
Dec 31, 2021 -1.49 Mn
Sep 30, 2021 -2.22 Mn
Jun 30, 2021 -3.58 Mn
Mar 31, 2021 -2.84 Mn
Dec 31, 2020 805,000.00
Sep 30, 2020 8.58 Mn
Jun 30, 2020 -5.01 Mn
Mar 31, 2020 -10.85 Mn
Dec 31, 2019 -549,000.00
Sep 30, 2019 -5.53 Mn